TLA
  • Twitter
  • GitHub
  • Home
  • TPS
  • BPLP

Insights

  • Point of Care: Interstate Licensing
  • Best Practices for Securing Data
  • Accelerating Tech Innovation
  • Point of Care: Telehealth + Critical Care
  • Maximize Impact, But Do No Harm
  • Infrastructure in a Disaster
  • The Critical Question for Data Science
  • Data Science Could Help Battle Wildfires
  • An EOC in Your Pocket
  • NETCCN Deployed Hospitals

Best Practices

  • Best Practices Articles

Learning Materials

  • APRED
  • Tele-Critical Care Hospitals Map
  • Other Resources

Articles

  • TCC Strategies for Covid-19
  • Tele-ICUs for Covid-19
  • Ventilator Stockpile for Covid-19
  • Cost-Effective ICU Telemedicine
  • Business Case for Tele-ICUs
  • Efficacy of Remote Critical Care

External Blogs

  • CDC COVID-19 News
  • Federal Telemedicine News
  • Public Health Emergency / ASPR Blog
  • The Digital Responder

COVID-19 Vaccines for Moderately to Severely Immunocompromised People

CDC recommends that moderately or severely immunocompromised people receive an additional dose of mRNA COVID-19 vaccine at least four weeks after a second dose of Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine.

🗓 Posted August 19, 2021 by undefined


Read the full article at https://tools.cdc.gov/api/embed/downloader/download.asp?m=404952&c=426099

Edit this page on GitHub

← Credit Suisse Hosts Accolade
Breastfeeding and Caring for Newborns if You Have COVID-19 ' CDC →
  • Powered by Crisis Technologies Innovation Lab at Indiana University
  • Home
  • Privacy
  • Contact